(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 18.72% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.64%.
Glaukos's revenue in 2025 is $469,820,000.On average, 18 Wall Street analysts forecast GKOS's revenue for 2025 to be $28,885,653,788, with the lowest GKOS revenue forecast at $27,219,471,981, and the highest GKOS revenue forecast at $29,914,884,329. On average, 18 Wall Street analysts forecast GKOS's revenue for 2026 to be $35,862,251,656, with the lowest GKOS revenue forecast at $34,086,943,843, and the highest GKOS revenue forecast at $37,395,184,867.
In 2027, GKOS is forecast to generate $45,709,437,829 in revenue, with the lowest revenue forecast at $40,407,636,980 and the highest revenue forecast at $50,470,777,775.